Skip to content
Screener

Establishment Labs ESTA Investing Cash Flow

Investing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$1.11B+93.9%
AbbVie logo
AbbVieABBV
-$574M+21.9%
IAR
Integra LifeSciencesIART
-$43.28M-99.9%
Artivion logo
ArtivionAORT
-$129.41M-3,837%
Globus Medical logo
Globus MedicalGMED
-$129.05M+56.9%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$12.65M-78.2%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Purchases of property and equipment(5,511)(2,377)
Cash used in business acquisitions, net of cash acquired(307)
Cost incurred for intangible assets(98)(723)
Net cash used in investing activities(5,609)(3,407)
Cash flows from financing activities:
Borrowings under Oaktree credit agreement265,000
Repayment of Oaktree credit agreement(246,367)
Payment of financing fees, Oaktree debt(10,006)

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's investing cash flow?
Establishment Labs (ESTA) reported investing cash flow of -$3.65M in Q2 2026.
How has Establishment Labs's investing cash flow changed year-over-year?
Establishment Labs's investing cash flow decreased by 76.2% year-over-year, from -$2.07M to -$3.65M.
What is the long-term trend for Establishment Labs's investing cash flow?
Over 4 years (2021 to 2025), Establishment Labs's investing cash flow has grown at a -0.5% compound annual growth rate (CAGR), from -$7.16M to -$7.03M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Establishment Labs's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude